NorthWest Biotherapeutics Inc (NWBO)

[AVII77]

"Lesion enlargement on first follow-up magnetic resonance imaging evidenced in 28 (44.4%) patients. Salvage pathologies revealed pseudoprogression in 12 of 28 (42.8%) patients corresponding to an overall pseudoprogression rate of 19%. "

Think about it folks, this isn't rocket science.

44.4% of the patients had "lesion enlargement" on first follow-up. (If they were being screened for the DCVax trial, this is the group who would be sent to the Info Arm)

Of those, they found that 42.8% were actually psPD. (and they didnt determine this with Macdonald or Rano, they CUT THEM WITH A KNIFE and collected a DIRECT SPECIMEN.)

The relevance? If you were to use this paper as a proxy, you would expect 42.8% of the patients in the Info Arm to have psPD.

Not 1 psPD patient as NWBO reported, but 22 psPD patients.

The Info Arm, as I've said repeatedly, is chock full of psPD patients.

And in their pathetic desperation, NWBO management were pumping the hell out of this psPD data suggesting to gullible investors that these patients are the sickest of the sick.

And so many here bought it hook, line and sinker.

..............
RKM, just got back in town. Will try to respond to your post(s) soon.